![Jeffrey Jacobs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Jacobs
Directeur Technique/Scientifique/R&D chez
FULCRUM THERAPEUTICS, INC.
Profil
Jeffrey W.
Jacobs is Chief Scientific Officer at Fulcrum Therapeutics, Inc. since 2022.
Former roles include Senior Director-Development Chemistry at Sunesis Pharmaceuticals, Inc. from 2000 to 2008; Vice President-Medicinal Chemistry at Ardelyx, Inc. from 2008 to 2011; Senior Director-Development Chemistry at Affymax, Inc.; Principal at Vicuron Pharmaceuticals LLC; Principal at The Damon Runyon Cancer Research Foundation; and Chief Scientific Officer at Goldfinch Bio, Inc. Education includes undergraduate studies at Gonzaga University and a doctorate from the University of California, Berkeley.
Postes actifs de Jeffrey Jacobs
| Sociétés | Poste | Début |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/12/2022 |
Anciens postes connus de Jeffrey Jacobs
| Sociétés | Poste | Fin |
|---|---|---|
| ARDELYX, INC. | Directeur Technique/Scientifique/R&D | 01/11/2021 |
| VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2008 |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Directeur Technique/Scientifique/R&D | - |
The Damon Runyon Cancer Research Foundation
 The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Corporate Officer/Principal | - |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | - |
Formation de Jeffrey Jacobs
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Gonzaga University
 Gonzaga University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Commercial Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Health Technology |
